Stocks

What We Know About the Ousting of MassRoots CEO Isaac Dietrich

What We Know About the Ousting of MassRoots CEO Isaac Dietrich

What We Know About the Ousting of MassRoots CEO Isaac Dietrich

On Oct. 16, 2017, the Board of Directors for MassRoots (OTCQB:MSRT), a marijuana social media platform, ousted Isaac Dietrich as the company’s Chairman and Chief Executive Officer.

Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion

Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion

Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.

Has This Top Marijuana Stock Weathered a Serious Storm?

Has This Top Marijuana Stock Weathered a Serious Storm?

The stock of MedReleaf Corp. has recently outperformed those of other top marijuana stock players in Canada, and there could be further price gains going forward after the recently listed cannabis firm has found its footing and stopped the earlier quarterly revenue declines.

Big Weed is on Board With Trudeau’s Marijuana Tax Plan

Big Weed is on Board With Trudeau’s Marijuana Tax Plan

Canada’s biggest medical cannabis producers are seeing their stock prices rise after the federal government announced a plan to levy a one dollar per gram tax on recreational marijuana sales.

Pot Investors: This Mistake Cost a Growth Company 35% of its Stock Price!

Pot Investors: This Mistake Cost a Growth Company 35% of its Stock Price!

Marijuana companies should be careful in overselling how much growth will be achieved or what the prospects will look like for the industry. There is a recent example that cannabis investors would be wise to review, and that’s what happened with Freshii Inc..

Marijuana Index Decreased 11% in August, Cancelling Out July’s Gains

Marijuana Index Decreased 11% in August, Cancelling Out July’s Gains

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 11% in August.

Why More Medical Marijuana IPOs Are Coming and Why You Should Avoid Them

Why More Medical Marijuana IPOs Are Coming

Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price.

The 1 Marijuana Stock That Can Thrive, Even If Jeff Sessions Cracks Down

The 1 Marijuana Stock That Can Thrive, Even If Jeff Sessions Cracks Down

Undoubtedly, a reversal in the federal government’s laxness on pot would be terrible news for marijuana stock investors, but not every last company would be decimated. One marijuana stock could still thrive, even with Jeff Sessions waving the metaphorical sword at the pot industry: Scotts Miracle-Gro.

Where Are Canadian Cannabis Stocks Headed From Here?

Where Are Canadian Cannabis Stocks Headed From Here?

With prices for many major Canadian cannabis stocks such as Canopy Growth Corp., Aphria Inc., and Aurora Cannabis Inc. trading sideways over the past few months, investors are now wondering which direction stocks will move from here, and what the long-term play with this industry is overall.

Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors

Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors

Canopy Growth Corp. (TSX:WEED) was the first cannabis stock to the market and quickly captured the attention of traders and risk-taking growth investors alike. As a result, shares of Canopy skyrocketed 300% in a span of just a few months last year.

Pixabay / rawpixel / CC0 Public Domain

Better Know a Marijuana Stock: Cronos Group

Whereas most weed businesses are working harder than ever to increase their grow capacity, Cronos Group is a company that’s trying to work smarter. Based in Canada, Cronos Group is an investment firm that primarily invests in Canadian-based pot companies involved in Canada’s medical-marijuana industry.

Marijuana Firm Says TMX Trade Shift Would Undermine System

Marijuana Firm Says TMX Trade Shift Would Undermine System

Any move by the Toronto Stock Exchange owner to stop settling trades for marijuana companies with U.S. operations would undermine the market’s regulatory system, according to one Canadian pot company.

Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?

Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?

TMX Group Ltd. (TSX:X), the operator of the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), has reportedly been speaking with regulators to figure out what will happen to Canadian marijuana producers with assets in the U.S.

TMX Says Lower Trading Volume Mostly Due to Avoidance of Pot Stocks

TMX Says Lower Trading Volume Mostly Due to Avoidance of Pot Stocks

TMX Group Ltd’s CEO on Thursday brushed off signs that the grip of Canada’s dominant stock exchange operator on overall trading volumes was slipping, saying recent market share losses were mostly due to its rejection of certain listings.

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors

The 1 Word in GW Pharmaceuticals’ Q3 Update That Disappointed Investors

When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.

Marijuana Index Increases 11% in July as US and Canadian Stocks Rebound

Marijuana Index Increases 11% in July as US and Canadian Stocks Rebound

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 11% in July. This marks the first positive month for the North American Index since January.

4 Canadian Marijuana Stocks in Great Financial Health

4 Canadian Marijuana Stocks in Great Financial Health

Identifying companies in great financial health is important when investing in an industry like marijuana. That being said, the Canadian marijuana stocks on our list all have current ratios of at least 10x, and debt to equity ratios under 20%.

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

In mid-June home lawn and fertilizer care specialist The Scotts Miracle-Gro Company (NYSE:SMG) lowered its full-year fiscal 2017 outlook, citing a more than 10% drop in mass retail sales compared to the year-to-date checkpoint from the previous year. That was caused by challenging weather this spring in core markets across the United States.

Flickr / Jen Montgomery / (CC BY-NC-ND 2.0)

The Average Marijuana Stock Is Up 332% Over the Past Year

Over the trailing-12-month period through July 15, the average marijuana stock with a market cap in excess of $200 million — a dozen stocks in total, which excluded MedReleaf because it just went public a month ago — was up by 332%.

Cara Therapeutics Stock Has Lost More Than Half Its Value in 2 Weeks

Cara Therapeutics Stock Has Lost More Than Half Its Value in 2 Weeks

On June 27, Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech company with a focus on treating chronic pain and pruritus, surged to an all-time intraday high of $28.50 a share. Cara was just $73 million away from joining the $1 billon market cap ranks.

Betting on Pot in the Stock Market - Canadian Cannabis

Betting on Pot in the Stock Market

Since Justin Trudeau’s election, the Canadian cannabis space has seen significant growth both in public and private sectors. The industry is gearing up for its entry into the legal recreational cannabis market set to open up by July 1, 2018.

Marijuana Index Dips 3% in June as Canadian Stocks Continue to Decline

Marijuana Index Dips 3% in June as Canadian Stocks Continue to Decline

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 3% in June as continued losses in Canada closed out the Index’s second worst performing quarter since its inception in January 2015.

Better Know a Marijuana Stock: MedReleaf Corp.

Better Know a Marijuana Stock: MedReleaf Corp.

MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. today is one of the pre-eminent marijuana producers listed on the TSX Venture Exchange with a market capitalization just shy of $750 million, making it the fourth-largest marijuana stock behind only GW Pharmaceuticals PLC- ADR, Canopy Growth Corp., and Aphria Inc.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.

SEC Calls Hemp Oil Fraud on Public Company

SEC Calls Hemp Oil Fraud on Public Company

On June 15, 2017, the United States Securities and Exchange Commission called hemp oil fraud on a public company, filing a complaint in federal court that claims CV Sciences (OTCQB:CVSI) , formerly known as CannaVEST, and its CEO, Michael Mona, Jr., intentionally overstated the company’s total assets.


Page 1 of 812345...Last »
Top